Browse Tag

AstraZeneca

London Stock Exchange at Record Highs – Inside the Historic Market’s Brexit Battle and 2025 Revival

UK stocks today (6 Nov 2025): FTSE 100 edges lower before BoE decision; Sainsbury lifts profit guidance, ITV warns on Q4 ads, AstraZeneca beats

LONDON — Thursday, 6 November 2025 At a glance Market snapshot: waiting on Threadneedle Street UK equities were fractionally lower by late morning, with traders staying cautious ahead of the Bank of England’s midday decision and press conference. The FTSE
6 November 2025
AstraZeneca (AZN) Stock Skyrockets: $50B U.S. Gamble, Trump Pricing Deal & Analyst Forecasts

AstraZeneca (AZN) Stock Skyrockets: $50B U.S. Gamble, Trump Pricing Deal & Analyst Forecasts

Company Background AstraZeneca PLC is a leading Anglo-Swedish pharmaceutical giant specializing in oncology, respiratory, cardiovascular/metabolic, and rare disease medicines marketbeat.com astrazeneca.com. Headquartered in Cambridge, UK, it maintains primary listings on the London Stock Exchange and Nasdaq Stockholm, with secondary ADR
Go toTop